PRMT5-Mediated ALKBH5 Methylation Promotes Colorectal Cancer Immune Evasion via Increasing CD276 Expression
Numerous diseases have been connected to protein arginine methylations mediated by protein arginine methyltransferase 5 (PRMT5). Clinical investigations of the PRMT5-specific inhibitor GSK3326595 are currently being conducted, and the results are promising for preventing cancers. However, the detail...
Saved in:
Main Authors: | Sen Meng, Hao Liu, Jiayu Xu, Chuyin Deng, Xingyou Qian, Sufang Chu, Wei-Guo Zhu, Jiuling Zhu, Hongmei Yong, Zhongwei Li, Jin Bai |
---|---|
Format: | Article |
Language: | English |
Published: |
American Association for the Advancement of Science (AAAS)
2025-01-01
|
Series: | Research |
Online Access: | https://spj.science.org/doi/10.34133/research.0549 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TRIM21-mediated PRMT1 degradation attenuates colorectal cancer malignant progression
by: Menghan Cao, et al.
Published: (2025-01-01) -
PRMT5 promotes ovarian cancer growth through enhancing Warburg effect by methylating ENO1
by: Fei Xie, et al.
Published: (2023-04-01) -
Prmt5 is essential for intestinal stem cell maintenance and homeostasis
by: Li Yang, et al.
Published: (2025-02-01) -
PRMT1-methylated MSX1 phase separates to control palate development
by: Li Meng, et al.
Published: (2025-01-01) -
Abnormal Decrease of Macrophage ALKBH5 Expression Causes Abnormal Polarization and Inhibits Osteoblast Differentiation
by: Junquan Weng, et al.
Published: (2023-01-01)